PER2 and cancer: Cancer cells also express higher levels of PER2 compared to normal cells; correspondingly, PER2 circadian expression has been shown to modulate proliferative, cell cycle, and apoptotic pathways, specifically c-myc, cyclin D, β-catenin, and VEGF (Zhang et al., 2001; Fu et al., 2002; Wood et al., 2008).